FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

29922811000001104: Trazodone 150mg tablets (Primegen Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93264601000001114 Trazodone 150mg tablets (Primegen Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111531101000001110 Trazodone 150mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trazodone 150mg tablets (Primegen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Is a Product containing precisely trazodone hydrochloride 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has active ingredient Trazodone hydrochloride false Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has specific active ingredient Trazodone hydrochloride true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Trazodone 150mg tablets (Primegen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Trazodone 150mg tablets (Primegen Ltd) 28 tablet 2 x 14 tablets Has AMP True Trazodone 150mg tablets (Primegen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start